SCHEMBL4539405

SCHEMBL4539405

O=C(NNc1ncc(C(F)(F)F)cc1Cl)c1cccn1-c1ccc(F)cc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.64
CYP3A4 P08684 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
SMN1; SMN2 Q16637 8/20 0.57
MAPT P10636 5/20 0.57
NPSR1 Q6W5P4 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
GAA P10253 10/20 0.53
KDM4E B2RXH2 2/20 0.53
POLB P06746 2/20 0.53
ALDH1A1 P00352 10/20 0.52
HTT P42858 7/20 0.52
AGTR1 P30556 5/20 0.52
GALR3 O60755 1/20 0.52
RAB9A P51151 1/20 0.52
PPARG P37231 1/20 0.49
NR2E3 Q9Y5X4 1/20 0.49
NCOR2 Q9Y618 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4543010 0.93 SMN1; SMN2 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL13707576 0.91 SMN1; SMN2 (0.58) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4540568 0.90 MAPT (0.59) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4539911 0.90 SMN1; SMN2 (0.56) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4543847 0.89 SMN1; SMN2 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4543827 0.89 SMN1; SMN2 (0.63) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4542435 0.87 SMN1; SMN2 (0.53) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4539879 0.87 SMN1; SMN2 (0.53) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4542470 0.87 MAPT (0.66) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4539551 0.86 SMN1; SMN2 (0.60) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed